Recent

% | $
Quotes you view appear here for quick access.

Pacific Biosciences of California, Inc. Message Board

  • jonathan.odom@rocketmail.com jonathan.odom Sep 26, 2013 10:29 AM Flag

    They should have sold the company versus 35M in onetime revenue and up to 40M in payments over life.

    Pacific Biosciences Announces Agreement With Roche Diagnostics: $35M upfront + up to $40M milestone payments

    Management equates to dunces. They bled the company and then this deal is a bandaid.
    Company loses greater than 80M a year. Trades at 3 to 5x valuation of any other peer. The IPO fed their ignorance. Will just be a quick drip to 4.50. One company I do like did a secondary today KBIO, rather good longer term hold. Lot's of institutional holding and buying, several catalysts over the next 9 months, did a secondary today at 4 which was BS, but a good buying opportunity.

    Sentiment: Sell

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
PACB
7.86-0.09(-1.13%)Jul 25 4:00 PMEDT